Resurgent Financial Advisors »

Crispr Therapeutics shares owned by Resurgent Financial Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Resurgent Financial Advisors from 13F filings

Historical chart of Resurgent Financial Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Resurgent Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Resurgent Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 402 62.60
2023-06-30 $23k 412 56.14
2022-12-31 $200k 4.9k 40.65
2022-09-30 $336k 5.2k 65.22
2022-06-30 $287k 4.7k 60.79
2022-03-31 $268k 4.3k 62.76